Request Expert

Expert’s primary experience in tablet manufacturing covered conventional pharmaceutical tablets for a variety of drugs and chewable tablets of antibiotics, utilizing both dry and wet granulation techniques and a variety of processing and tablet equipment. His experience encompasses all aspects of tablet production from the receipt of QC-released active ingredients, inert ingredients or excipients, and packaging and labeling materials, selection and calibration of production and testing equipment and apparatus, combination and blending of solids, wet and dry granulation and screening or direct compression, drying and sizing as necessary, blending of granulation intermediates or direction compression powders with lubricants, glydants, flavoring and sweetening agents, lakes and dyes, binders, moisture scavengers, and other required excipients. Drug products manufactured included generic and new drug agents, prescription and non-prescription drug products. Production of conventional and chewable tablets would be considered his specialty, although he has supervised the manufacturing of capsules and a variety of other oral and topical pharmaceutical dosage forms including solutions, suspensions, lotions, creams and ointments.

Expert's career in industrial pharmacy includes solid oral form manufacturing at a major prescription drug manufacturer where he improved already marketed products and developed new drug products for basic new drug entities through pilot production scale-up and routine followup trouble-shooting of production problems thereafter.
Expert began his career in pharmaceutical manufacturing as a manufacturing pharmacist upon enrollment in graduate studies in industrial pharmacy at a major university college of pharmacy. He supervised compounding and manufacturing of a variety of non-prescription (OTC) oral liquid and solid dosage forms, as well as liquid and semi-solid topical preparations (creams, lotions and ointments), and nasal solutions (drops and sprays) in accordance with FDA procedures. Additional functions included filling and packaging, labeling, inventory control, and distribution to institutional outlets such as University Health Services.
His industrial and systems engineering background have proved particularly valuable during his career in pharmaceutical manufacturing. As president of a generic drug manufacturing firm, he developed the business plan, secured finances for, designed plant layout, equipped, furnished, initiated start-up of and managed the pharmaceutical manufacturing plant. He managed procurement marketing to local, state and federal government clients, and supervised pharmaceutical manufacturing operations. He also designed and advised principals on pharmaceutical manufacturing feasibility studies domestically and internationally, including FDA regulatory requirements and procedures.

For more than 16 years, Expert has designed and developed various solid and liquid oral dosage forms from concept to pharmaceutical pilot production scale-up and followup trouble-shooting of production problems. His R&D experience includes stability testing of bulk active drug ingredients, experimental mixtures for preparation of intermediates, containers and closures under various environmental conditions of temperature, humidity, light, and vibration. He is experienced in the selection, sourcing, purchasing and evaluation of raw materials – binders, granulating agents, colorants (food grade dyes and lakes), lubricants, solvents, disintegrating agents, glidants, etc. – as well as equipment and apparatus for dissolution, disintegration, friability and hardness testing; comminuting, screening, mixing and blending powders and granulates; production of conventional, chewable and specialized tablets, capsules, and oral and topical liquids and semi-solids; counting, filling, packaging and labeling for major brands and generic drug manufacturing.


Expert’s experience in pharmaceutical research and development included research administration as Technical Assistant to the Vice President for Medicinal Products Research and Development, Secretary of the Corporate Medical Research Committee, Project Leader of Pharmaceutical Research, and Senior Research Scientist. In addition to his scientific research performed, he devised the corporation’s first systems manual for coordinating world-wide pharmaceutical research projects and programs and supervised the clinical formulation unit. He prepared or supervised preparation of new drug IND formulation and labeling submissions. He also designed new research and development facilities for consolidation of previously geographically separate domestic pharmaceutical product R&D operations at a multi-national drug manufacturer. As Project Leader and Senior Research Scientist, he stream-lined procedures for a broad variety of conventional and controlled release oral and topical liquid and solid dosage forms, from new drug physical pharmacy characterization testing and compatibility screening through dosage form design and development, product stability testing, disintegration and dissolution testing, friability testing, specialized testing as required, container and closure evaluation and selection, through pilot production scale-up and trouble-shooting in manufacturing of new and established pharmaceutical products.


The Expert patented a controlled release delivery system tablets and capsules at Pfizer, one of the world’s largest pharmaceutical manufacturers. Before industry, he studied the effects of variables on the release properties of controlled release particles as the subject of his doctoral dissertation and subsequently designed, researched and developed his invention in the pharmaceutical industry. With this invention, Expert salvaged an entire existing product line of an unstable cardiac medication, extended its commercial shelf-life, and achieved predictable drug release patterns for these products. His controlled release technology has been used in various sustained release formulations for new medical entities and for existing product improvements. Expert's controlled release technology utilizes a balance of hydrophilic/hydrophobic matrices prepared by direct compression, and is modifiable for use with wet or dry granulation techniques, to accommodate differing compressibility and release properties of active drugs and excipients.

Array

As the pharmaceutical expert on a World Bank consulting team, he advised the Ministry of Health and evaluated the Ethiopia's plans for upgrading and expanding its national pharmaceutical supply logistics program components, including its own in-country manufacturing facilities, R&D and Quality Control facilities, manufacturing plant expansion, procurement, quality control, importation, demand forecasting, and country-wide distribution of pharmaceuticals.As leader of medical and pharmaceutical supply logistics management team, he reviewed the Government of Jamaica's pharmaceutical procurement, warehousing, distribution and cold chain and supervised other team pharmacists in their conduct of component analyses and compilation of associated components of final report to the U.S. Agency for International Development; and provided recommendations for improvements in all aspects of the USAID-funded pharmaceutical management project. He also collaborated with the College of Arts, Science and Technology on formulation research on oral re-hydration salt products.On assignment with the U.S. Department of State, he made recommendations to Jordanian pharmacists at the Jordanian Pharmaceutical Association on the rationale and procedure for incorporating clinical training of pharmacists in their professional curriculum in Jordan.He evaluated client proposals and established a checklist for use in preparing grant proposals to the U.S. Centers for Disease Control and Prevention Community Based Care Transitions Program aimed at preventing the re-hospitalization of patients, using medication therapy management methodology and adherence, compliance and persistence systems by a pharmaceutical consulting firm specializing in the management of diabetes and co-morbid conditions.